Title

Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis

Publication/Presentation Date

4-2019

Abstract

A patient with Multifocal Reticulohistiocytosis (MRH) of skin and joints failed treatment with etanercept, methotrexate, hydroxychloroquine, prednisone, bisphosphonates and hydroxyzine. Long term treatment with thalidomide led to marked improvement in joint and cutaneous manifestations.

Volume

4

Issue

1

First Page

1

Last Page

3

ISSN

2684-124X

Disciplines

Hematology | Medicine and Health Sciences | Oncology | Pediatrics

Peer Reviewed for front end display

Peer-Reviewed

Department(s)

Department of Pediatrics, Department of Pediatrics Faculty

Document Type

Article

Share

COinS